- Home
- ERAS vs ALRS Comparison
ERAS vs ALRS Comparison
Compare ERAS & ALRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- ALRS
- Stock Information
- Founded
- ERAS 2018
- ALRS 1879
- Country
- ERAS United States
- ALRS United States
- Employees
- ERAS N/A
- ALRS N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- ALRS Major Banks
- Sector
- ERAS Health Care
- ALRS Finance
- Exchange
- ERAS Nasdaq
- ALRS Nasdaq
- Market Cap
- ERAS 396.6M
- ALRS 468.2M
- IPO Year
- ERAS 2021
- ALRS 2019
- Fundamental
- Price
- ERAS $1.43
- ALRS $20.98
- Analyst Decision
- ERAS Strong Buy
- ALRS Hold
- Analyst Count
- ERAS 6
- ALRS 5
- Target Price
- ERAS $4.83
- ALRS $23.20
- AVG Volume (30 Days)
- ERAS 1.5M
- ALRS 76.7K
- Earning Date
- ERAS 05-20-2025
- ALRS 04-28-2025
- Dividend Yield
- ERAS N/A
- ALRS 3.77%
- EPS Growth
- ERAS N/A
- ALRS 118.02
- EPS
- ERAS N/A
- ALRS 1.08
- Revenue
- ERAS N/A
- ALRS $224,218,000.00
- Revenue This Year
- ERAS N/A
- ALRS $36.47
- Revenue Next Year
- ERAS N/A
- ALRS $4.64
- P/E Ratio
- ERAS N/A
- ALRS $19.56
- Revenue Growth
- ERAS N/A
- ALRS 35.73
- 52 Week Low
- ERAS $1.01
- ALRS $15.78
- 52 Week High
- ERAS $3.45
- ALRS $24.41
- Technical
- Relative Strength Index (RSI)
- ERAS 52.92
- ALRS 71.39
- Support Level
- ERAS $1.37
- ALRS $20.82
- Resistance Level
- ERAS $1.61
- ALRS $21.39
- Average True Range (ATR)
- ERAS 0.14
- ALRS 0.67
- MACD
- ERAS 0.00
- ALRS 0.36
- Stochastic Oscillator
- ERAS 53.09
- ALRS 92.05
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About ALRS Alerus Financial Corporation
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.